Subscribe to Newsletter
Business & Profession Other

Foreign Device Trial Data Fine With FDA

The FDA has released draft guidance (1) stating it will accept “valid” foreign clinical trial data in support of premarket submissions for medical devices to be released in the USA. It turns out they already did – with the proviso that “special considerations” are applied “when using such data, including applicability to populations within the United States and study design issues” – it’s just that their position could have been clearer. So to avoid companies performing “unnecessary duplicate studies” and to “further efforts to harmonize global clinical trial standards, and promote public health and innovation,” they’ve issued this guidance.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. Office of the Federal Register, “Acceptance of medical device clinical data from studies conducted outside the United States; draft guidance for industry and food and drug administration staff; availability”, (2015). Available at: Accessed April 24, 2015.
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: